{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/DDT"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DDT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DDT\",,,,,undefined,":{"symbol":"DDT","market":"US","secType":"STK","nameCN":"Dillard's Capital Trust I","latestPrice":26.086,"timestamp":1750449600000,"preClose":26.02,"halted":0,"volume":6900,"hourTrading":{"tag":"盘后","latestPrice":26.086,"preClose":26.086,"latestTime":"16:04 EDT","volume":1,"amount":26.086,"timestamp":1750449846186},"delay":0,"floatShares":8000000,"shares":8000000,"eps":0,"marketStatus":"Market Closed","change":0.066,"latestTime":"06-20 16:00:00 EDT","open":26.02,"high":26.12,"low":25.95,"amount":179662.6389,"amplitude":0.006533,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":26.02,"postHourTrading":{"tag":"盘后","latestPrice":26.086,"preClose":26.086,"latestTime":"16:04 EDT","volume":1,"amount":26.086,"timestamp":1750449846186},"volumeRatio":1.3356561981921462},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DDT\",,,,,undefined,":{"symbol":"DDT","floatShares":8000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.3356561981921462,"shares":8000000,"dividePrice":0,"high":26.12,"amplitude":0.006533,"preClose":26.02,"low":25.95,"week52Low":24.39,"pbRate":"--","week52High":26.55,"institutionHeld":0,"latestPrice":26.086,"eps":0,"divideRate":0,"volume":6900,"delay":0,"ttmEps":0,"open":26.02,"prevYearClose":25.71,"prevWeekClose":26.09,"prevMonthClose":25.98,"prevQuarterClose":25.65,"fiveDayClose":26.14,"twentyDayClose":25.8822,"sixtyDayClose":26.25},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DDT\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DDT\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507621421","title":"Creative Medical reports data from first cohort in Phase 1/2 CELZ-201-DDT trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621421","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507621421?lang=en_us&edition=fundamental","pubTime":"2025-01-30 22:30","pubTimestamp":1738247437,"startTime":"0","endTime":"0","summary":"Creative Medical Technology (CELZ) announced initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT, the Compan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/creative-medical-reports-data-from-first-cohort-in-phase-1-2-celz-201-ddt-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/creative-medical-reports-data-from-first-cohort-in-phase-1-2-celz-201-ddt-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CELZ","DDT","BK4139"],"gpt_icon":0},{"id":"2507621819","title":"Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621819","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507621819?lang=en_us&edition=fundamental","pubTime":"2025-01-30 22:25","pubTimestamp":1738247100,"startTime":"0","endTime":"0","summary":"PHOENIX, Jan. 30, 2025  -- Creative Medical Technology Holdings, Inc. , a clinical-stage biotechnology company focused on regenerative medicine, today announced promising initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT, the Company’s proprietary stem cell-based therapeutic for the treatment of chronic back pain caused by degenerative disc disease .The first cohort of 10 participants  completed the study phase without any dose-limiting toxicities or serious adverse events. Blinded preliminary data suggest encouraging therapeutic potential in alleviating back pain and restoring functionality. Following a comprehensive safety review, the independent Data Safety Monitoring Board  recommended the trial proceed to the next cohort as planned.Safety Confirmed: CELZ-201-DDT demonstrated an excellent safety profile, with no serious adverse events reported in the first cohort.About CELZ-201-DDTCELZ-201-DDT is a proprietary regenerative stem cell-based th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/creative-medical-technology-holdings-announces-142500258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4551","BK4585","BK4170","DDD","BK4139","BK4161","BK4546","DDT","BK4588","CELZ"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DDT\",params:#limit:5,,,undefined,":[{"date":"2025-07-17","symbol":"DDT","amount":0.46875,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-17","defaultRemindTime":1752759000000,"name":"Dillard's Capital Trust I","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-01","payableDate":"2025-07-17","currency":"USD","dateTimestamp":1752724800000,"payDate":"2025-08-01"},{"date":"2025-04-16","symbol":"DDT","amount":0.46875,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-16","defaultRemindTime":1744810200000,"name":"Dillard's Capital Trust I","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-01","payableDate":"2025-04-16","currency":"USD","dateTimestamp":1744776000000,"payDate":"2025-05-01"},{"date":"2025-01-17","symbol":"DDT","amount":0.46875,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-17","defaultRemindTime":1737124200000,"name":"Dillard's Capital Trust I","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-03","payableDate":"2025-01-17","currency":"USD","dateTimestamp":1737090000000,"payDate":"2025-02-03"},{"date":"2024-10-17","symbol":"DDT","amount":0.46875,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-10-17","defaultRemindTime":1729171800000,"name":"Dillard's Capital Trust I","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-01","payableDate":"2024-10-17","currency":"USD","dateTimestamp":1729137600000,"payDate":"2024-11-01"},{"date":"2024-07-17","symbol":"DDT","amount":0.46875,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-07-17","defaultRemindTime":1721223000000,"name":"Dillard's Capital Trust I","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-01","payableDate":"2024-07-17","currency":"USD","dateTimestamp":1721188800000,"payDate":"2024-08-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DDT\",market:\"US\",,,undefined,":[{"executeDate":"2017-01-12","recordDate":"2017-01-17","paymentDate":"2017-02-01","value":0.469,"currency":"USD"},{"executeDate":"2017-04-11","recordDate":"2017-04-13","paymentDate":"2017-05-01","value":0.469,"currency":"USD"},{"executeDate":"2017-07-13","recordDate":"2017-07-17","paymentDate":"2017-08-01","value":0.469,"currency":"USD"},{"executeDate":"2017-10-16","recordDate":"2017-10-17","paymentDate":"2017-11-01","value":0.469,"currency":"USD"},{"executeDate":"2018-01-16","recordDate":"2018-01-17","paymentDate":"2018-02-01","value":0.469,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DDT\",market:\"US\",delay:false,,,undefined,":{}}}